Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media.

Here, we have found that type 2 iodothyronine deiodinase (D2) is present in rat aorta media and that there is a circadian variation in the D2 expression. The D2 mRNA was approximately 4-fold higher at 0900 h than at 2100 h, and the activity was approximately 6-fold higher at noon than at 2100 h. The increase in aorta media D2 activity is preceded by the increase in its mRNA. The increase in D2 mRNA and activity in the circadian variation was reduced by the administration of prazosin, an alpha1-adrenergic antagonist, and propranolol, a beta- adrenergic antagonist. Furthermore, phenylephrine, an alpha1-adrenergic agonist, and isoproterenol, a beta-adrenergic agonist, caused a significant increase in D2 mRNA and activity. In the hypothyroid rats, aorta mediae D2 mRNA at both 0900 and 2100 h were not significantly different when compared with those in the euthyroid rats. On the other hand, aorta mediae D2 activity at both 1200 and 2100 h in the hypothyroid rats were approximately 2-fold higher. From these results, we suggest that D2 activity of rat aorta media is increased by both alpha1- and beta-adrenergic stimulation, at least partly, at the pretranslational level. We also suggest that both alpha1- and beta-adrenergic mechanisms may be involved, at least partly, in the circadian variation of the activity. In the hypothyroid state, the aorta media D2 activity is increased mainly by the posttranslational mechanism, and the similar circadian variation of the D2 expression is present as in the euthyroid state.

[1]  T. Iwasaka,et al.  Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells , 2003, Molecular and Cellular Endocrinology.

[2]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[3]  S. Fiering,et al.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. , 2001, Molecular endocrinology.

[4]  J. Harney,et al.  The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. , 2001, The Journal of clinical investigation.

[5]  T. Iwasaka,et al.  Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. , 2001, Thyroid : official journal of the American Thyroid Association.

[6]  H. Mizuma,et al.  Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells: Expression of Type II Iodothyronine Deiodinase , 2001, Circulation research.

[7]  J. Harney,et al.  Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. , 2000, Molecular Endocrinology.

[8]  F. Sannajust,et al.  Diurnal rhythms of blood pressure, heart rate, and locomotor activity in adult and old male Wistar rats , 2000, Physiology & Behavior.

[9]  J. Harney,et al.  Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. , 2000, Endocrinology.

[10]  Y Hosoi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells* , 2022 .

[11]  F. Soria,et al.  Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays. , 1999, Clinical biochemistry.

[12]  H. Mizuma,et al.  Pretranslational Regulation of Rhythmic Type II Iodothyronine Deiodinase Expression by β-Adrenergic Mechanism in the Rat Pineal Gland. , 1999, Endocrinology.

[13]  J. Harney,et al.  Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction* * This work was supported by NIH Grant DK-36256. , 1998, Endocrinology.

[14]  J. Harney,et al.  Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. , 1998, The Journal of clinical investigation.

[15]  H. Mizuma,et al.  Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland. , 1998, Life sciences.

[16]  L. Burmeister,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Thyroid Hormones Inhibit Type 2 Iodothyronine Deiodinase in the Rat Cerebral Cortex by Both Pre- and , 2022 .

[17]  F. Sellke,et al.  The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.

[18]  C. Hessenius,et al.  Evidence for Circadian Variations of Thyroid Hormone Concentrations and Type II 5′‐Iodothyronine Deiodinase Activity in the Rat Central Nervous System , 1997, Journal of neurochemistry.

[19]  I. Klein,et al.  Acute effects of thyroid hormone on vascular smooth muscle. , 1996, Thyroid : official journal of the American Thyroid Association.

[20]  J. Harney,et al.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid. , 1996, The Journal of clinical investigation.

[21]  J. Harney,et al.  Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. , 1996, Endocrinology.

[22]  J. Davey,et al.  Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. , 1996, The Journal of clinical investigation.

[23]  R. Reiter,et al.  Adrenergic regulation of type II 5'-deiodinase circadian rhythm in rat harderian gland. , 1992, The American journal of physiology.

[24]  P. Larsen,et al.  α1- and β-Adrenergic Agents Cause Synergistic Stimulation of the Iodothyronine Deiodinase in Rat Brown Adipocytes* , 1989 .

[25]  M. Greer,et al.  Evidence that Rat Pineal Thyroxine 5′-Deiodinase is Primarily Stimulated by β- and not α-Adrenergic Agonists and that Its Adrenergic-Stimulated and Spontaneous Rhythmic Nocturnal Rise Require RNA and Protein Synthesis , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  A. Sudo Circadian variation in urinary adrenaline levels in the rat after swimming exposure. , 1989, Industrial health.

[27]  M. Greer,et al.  Rhythmicity of triiodothyronine generation by type II thyroxine 5'-deiodinase in rat pineal is mediated by a beta-adrenergic mechanism. , 1987, Endocrinology.

[28]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[29]  B. Westerink,et al.  Circadian variation of catecholamine excretion in rats: Correlation with locomotor activity and effects of drugs , 1986, Neuropharmacology.

[30]  P. Larsen,et al.  Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5'-deiodinases by thyroid hormone. , 1984, Endocrinology.

[31]  P. Larsen,et al.  Adrenergic activation of triiodothyronine production in brown adipose tissue , 1983, Nature.

[32]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.